Mirum Pharmaceuticals, Inc. MIRM Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s total operating expenses?
- Mirum Pharmaceuticals, Inc. (MIRM) reported total operating expenses of $949.35M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s total operating expenses changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s total operating expenses increased by 648.9% year-over-year, from $126.77M to $949.35M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s total operating expenses has grown at a 29.6% compound annual growth rate (CAGR), from $192.55M to $543.45M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.